These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 239836)

  • 21. The effects of the dietary compound L-sulforaphane against respiratory pathogens.
    Mazarakis N; Higgins RA; Anderson J; Toh ZQ; Luwor RB; Snibson KJ; Karagiannis TC; Do LAH; Licciardi PV
    Int J Antimicrob Agents; 2021 Dec; 58(6):106460. PubMed ID: 34695564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxycycline in the treatment of upper and lower respiratory tract infections. A field trial.
    Titscher R
    Chemotherapy; 1975; 21 Suppl 1():109-15. PubMed ID: 1098871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute respiratory tract infections with doxycycline in general practice.
    Luitse S; Franssen RM; Hogenboom RM; Hengeveld WL
    Chemotherapy; 1975; 21 Suppl 1():136-42. PubMed ID: 1098873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Yokoyama M
    Jpn J Antibiot; 2001 May; 54 Suppl B():88-90. PubMed ID: 12638152
    [No Abstract]   [Full Text] [Related]  

  • 26. Doxycycline in respiratory infections: a re-assessment after 17 years.
    Maesen FP; Davies BI; van Noord JA
    J Antimicrob Chemother; 1986 Oct; 18(4):531-6. PubMed ID: 3771434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
    Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Empyema: bacterial epidemiology and antibiotic resistance].
    Vu-Thien H
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S81-3. PubMed ID: 19000860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infections of the lower respiratory tract in general practice].
    Cazzola M
    Infection; 1987; 15 Suppl 3():S113-9. PubMed ID: 3497107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections.
    Bantar C; Nicola F; Fernandez Canigia L; Arenoso HJ; Soutric J; Montoto M; Blanco M; Smayevsky J; Jasovich A
    J Chemother; 2000 Jun; 12(3):223-7. PubMed ID: 10877517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multi-centre trial of alpha-6-desoxy-5-oxytetracycline (doxycycline).
    Serembe M
    Chemotherapy; 1975; 21 Suppl 1():121-9. PubMed ID: 1098872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Discussions on PRSP and BLNAR].
    Tajima T; Meguro H; Akita H; Iwata T
    Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of injectable carbapenems for respiratory infections caused by Streptococcus pneumoniae and Haemophilus influenzae with Monte Carlo simulation].
    Mikamo H; Tanaka K; Watanabe K
    Jpn J Antibiot; 2007 Feb; 60(1):47-57. PubMed ID: 17436862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae.
    Sato T; Kawai Y; Matsuda H; Tateda K; Kimura S; Ishii Y; Yamaguchi K; Gotoh N
    J Antimicrob Chemother; 2011 Jul; 66(7):1547-54. PubMed ID: 21511823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Useful and superfluous measures in the treatment of respiratory infections].
    Mombelli G
    Schweiz Rundsch Med Prax; 1982 Nov; 71(46):1812-5. PubMed ID: 7178036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute exacerbations of chronic bronchitis with clindamycin.
    Ormonde NW; Gould JC; Degnen F; Munro AH; Munro JF
    Curr Med Res Opin; 1973; 1(7):390-4. PubMed ID: 4149253
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute otitis media caused by Streptococcus pyogenes in children.
    Segal N; Givon-Lavi N; Leibovitz E; Yagupsky P; Leiberman A; Dagan R
    Clin Infect Dis; 2005 Jul; 41(1):35-41. PubMed ID: 15937760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriology of the tracheobronchial system].
    Knothe H
    Internist (Berl); 1971 Oct; 12(10):442-4. PubMed ID: 4399107
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
    Watanuki Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():502-7. PubMed ID: 17455671
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rational antibiotic therapy of acute upper respiratory tract infections].
    Mazur E
    Pol Merkur Lekarski; 2010 Nov; 29(173):304-8. PubMed ID: 21268914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.